| CAS No. | 98626-61-0 |
| Molecular Formula | C17H26N2O |
| Molecular Weight | 274.40 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
The occurrence of Bupivacaine Impurity 33 is closely related to a steroid core, an amide group, a hydroxyl group, an ether linkage in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
Bupivacaine Impurity 33 (CAS 98626-61-0) is a certified pharmaceutical impurity reference standard with the molecular formula C17H26N2O and a molecular weight of 274.40 g/mol.
Owing to a steroid core, an amide group, a hydroxyl group, an ether linkage, Bupivacaine Impurity 33 is typically off-white to pale yellow low-melting solid. Its solid-state physicochemical attributes — including a molecular weight of 274.40 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
| Molecular Formula | C17H26N2O |
| Molecular Weight | 274.40 g/mol |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1985 |
| Nitrogen Atoms | 2 |